Quality of life for long-term sarcoma survivors
Part of Cancer clinical trials.
This study looks at the quality of life and medical care for people who have had sarcoma (including soft tissue, bone, or GIST) for at least 5 years. It aims to understand how survivors are doing and how their care can be improved.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with sarcoma (soft tissue, bone, or GIST) at least 5 years ago
- You are 18 years or older
- Your tumor may be active or not—both are okay
- You can read and understand German well enough to fill out a questionnaire
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study gathers information from people diagnosed with sarcoma (a bone or soft-tissue cancer) and their family members to learn what life is like after diagnosis. It is open to patients of any age, as well as their parents, caregivers, and older siblings.
This study tests whether adding palliative care early on to standard cancer treatment improves quality of life for people newly diagnosed with advanced or metastatic soft tissue sarcoma.
This study follows adults with gastrointestinal cancer or sarcoma to better understand how patients do after treatment and what side effects happen. It may help researchers improve care for future patients by documenting real-world outcomes and toxicities.
This study looks at how exercise habits are linked to how cancer survivors feel and their health outcomes. It may help understand if starting to exercise improves well-being.
This observational study looks at information from people with sarcoma to understand how care is delivered across different centers. It does not test a new treatment, but may help improve future care and planning.
This study checks how people with leg sarcoma are functioning and how satisfied they are with their quality of life after treatment. It mainly looks at patients at least one year after limb-sparing surgery, to understand long-term effects and support.
Hear when a new Sarcoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.